reference
The Food and Drug Administration's January 2025 draft guidance on AI-enabled medical devices recommends rigorous performance evaluation using metrics such as the area under the receiver operating characteristic curve and positive or negative likelihood ratios.
Authors
Sources
- On Hallucinations in Artificial Intelligence–Generated Content ... jnm.snmjournals.org via serper
Referenced by nodes (2)
- United States Food and Drug Administration entity
- AUROC concept